Tirzepatide CAS:2023788-19-2 Manufacturer Supplier

Tirzepatide yakagadzirwa seyakaviri agonist kune ese GLP-1 uye gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018).Zvakafanana neGLP-1, GIP inonzi incretin hormone inoshanda kuunza insulin secretion.Tirzepatide iri muchikamu chechitatu chekukura kwevanhu vakuru vane kufutisa kana kuwandisa vane uremu hunoenderana nehuremu uye parizvino iri pasi pekuongororwa kwemutemo sekurapa kwevakuru vane Type 2 chirwere cheshuga. .Iri kuongororwa zvakare semushonga ungangoita weasiri doro steatohepatitis (NASH) uye kutadza kwemoyo ine yakachengetedzwa ejection chikamu (HFpEF).

Order kana Kumbira Quote

Product Detail

Product Tags

Application uye Effect

Tirzepatide inoshandiswa nekudya kwakakodzera uye chirongwa chekurovedza muviri kudzora shuga yakakwira yeropa muvanhu vane chirwere cheshuga chechipiri.Kudzora shuga yakakwira yeropa kunobatsira kudzivirira kukuvadzwa kweitsvo, upofu, matambudziko etsinga, kurasikirwa nemakumbo, uye matambudziko ekuita zvepabonde.Tirzepatide ine hukama hukuru kune GIP receptors pane GLP-1 receptors, uye iyi mbiri agonist maitiro akaratidzwa kuburitsa zvakanyanya kuderedza. ye hyperglycemia ichienzaniswa neanosarudza GLP-1 receptor agonist.Zviratidzo zvidzidzo zvakaratidza kuti izvi zvinokonzerwa netirzepatide kutevedzera zviito zveGIP chaiyo paGIP receptor.

Product Sample

Product Packing:

Ruzivo Rwokuwedzera:

Composition	Na
Assay	99%
Chitarisiko	Upfu chena
CAS Nha.	2023788-19-2
Packing	25KG
Sherufu Hupenyu	2 years
Storage	Chengetedza munzvimbo inotonhorera uye yakaoma
Certification	ISO.